RT Journal Article
SR Electronic
T1 Children develop strong and sustained cross-reactive immune responses against Spike protein following SARS-CoV-2 infection, with enhanced recognition of variants of concern
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.12.21255275
DO 10.1101/2021.04.12.21255275
A1 Alexander C. Dowell
A1 Megan S. Butler
A1 Elizabeth Jinks
A1 Gokhan Tut
A1 Tara Lancaster
A1 Panagiota Sylla
A1 Jusnara Begum
A1 Hayden Pearce
A1 Eliska Spalkova
A1 Sandra Margielewska-Davies
A1 Graham S. Taylor
A1 Eleni Syrimi
A1 Frances Baawuah
A1 Joanne Beckmann
A1 Ifeanyichukwu Okike
A1 Shazaad Ahmad
A1 Joanna Garstang
A1 Andrew J Brent
A1 Bernadette Brent
A1 Georgina Ireland
A1 Felicity Aiano
A1 Zahin Amin-Chowdhury
A1 Samuel Jones
A1 Ray Borrow
A1 Ezra Linley
A1 John Poh
A1 Vanessa Saliba
A1 Gayatri Amirthalingam
A1 Kevin E Brown
A1 Mary E Ramsay
A1 Jianmin Zuo
A1 Paul Moss
A1 Shamez Ladhani
YR 2021
UL http://medrxiv.org/content/early/2021/04/29/2021.04.12.21255275.abstract
AB SARS-CoV-2 infection is generally mild or asymptomatic in children but the biological basis for this is unclear. We studied the profile of antibody and cellular immunity in children aged 3-11 years in comparison with adults. Antibody profiles in children were strong, with high titres against Spike protein and receptor binding domain (RBD). SARS-CoV-2 seroconversion in children strongly boosted antibody responses against seasonal beta-coronaviruses, partly through cross-recognition of the S2 domain, indicating a broad humoral response that was not seen in adults. T cell responses against Spike were also >2-fold higher in children compared to adults and displayed a strong Th1 cytokine profile. SARS-CoV-2 Spike-reactive cellular responses were present in more than half the seronegative children, indicating pre-existing cross-reactive responses or prior sensitization against SARS-CoV-2. Importantly, all children retained high antibody titres and cellular responses for more than 6 months after infection whilst relative antibody waning was seen in adults. Significantly Children at this timepoint also had high antibody titres to B1.1.7, B1.351 and P1 variants. Children thus distinctly generate robust, cross-reactive and sustained immune responses after SARS-CoV-2 infection, with focussed specificity against Spike protein. These observations demonstrate several novel features of SARS-CoV-2-specific immune responses in children and may provide insights into relative clinical protection in this group. Such information on the profile of natural infection will help to guide the introduction of vaccination regimens into the paediatric population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was part funded by the UK Coronavirus Immunology Consortium (UK-CIC), MRC and the UK Department of Health and Social Care.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:PHE Research Ethics Governance Group (reference NR0209; May 16, 2020)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available following reasonable requests.